Stockreport

Eli Lilly Obesity Pill Maintains Weight Loss After Wegovy, Zepbound [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF sustain most of their weight loss after switching from the company's injection Zepbound and Novo Nordisk's Wegovy in a late-stage study. Is LLY fairly valued? Test you [Read more]